IP Library › Granted Patent US 8,071,349
Granted Patent B2
US 8,071,349 · App. 11/938,932 · Granted Dec 6, 2011

BGL4 beta-glucosidase and nucleic acids encoding the same

Assignee: Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,349
App. No.
11/938,932
Granted
Dec 6, 2011
Kind
B2
Abstract

The present invention provides a novel β-glucosidase nucleic acid sequence, designated bgl4, and the corresponding BGL4 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL4, recombinant BGL4 proteins and methods for producing the same.

Claims (5)

1. A composition comprising an isolated polypeptide obtained from Trichoderma comprising at least 95% sequence identify to SEQ ID NO:2, which polypeptide has beta-glucosidase activity.

2. A composition comprising an isolated polypeptide comprising SEQ ID NO:2 obtained from Trichoderma.

3. A composition comprising an isolated fragment of SEQ ID NO:2, wherein the isolated fragment has beta-glucosidase activity.

4. A composition comprising an isolated polypeptide prepared by transforming a host cell with a nucleic acid sequence encoding the amino acid sequence of SEQ ID NO:2.

5. A composition comprising an isolated polypeptide prepared by transforming a host cell with a nucleic acid sequence encoding an amino acid sequence with at least 95% sequence identify to SEQ ID NO:2, which polypeptide has beta-glucosidase activity.

Assignments (1)
CHANGE OF NAME Recorded Dec 15, 2010
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 025504/0291 →
Continuity (2)
Division 10027000 · Dec 18, 2001
Related Publication 20110086410A1 · Apr 14, 2011